Neovascularization around the optic nerve in giant cell arteritis [3]

Arthritis Care and Research

Volumn 49, Issue 5, 2003, Pages 737-738

  Garcia Porrua, Carlos ^a   Pego Reigosa, Robustiano ^a   Armesto, Victor ^a   Gonzalez Gay, Miguel A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PREDNISONE;

AGED; ANGIOGENESIS; CASE REPORT; CELL PROLIFERATION; GIANT CELL ARTERITIS; HUMAN; LETTER; MALE; MOBILIZATION; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; TRANSITIONAL BLINDNESS; VASCULAR SMOOTH MUSCLE;

AGED; ASPIRIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOVASCULARIZATION, PATHOLOGIC; OPTIC NERVE; PREDNISOLONE; TEMPORAL ARTERITIS; TREATMENT OUTCOME;

EID: 0142095083     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Kaiser M, Younge B, Bjornsson J, Goronzy JJ, Weyand CM. Formation of new vasa vasorum in vasculitis: production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999;155:765-74.
2. Weyand CM, Goronzy JJ. Pathogenic principles in giant cell arteritis. Int J Cardiol 2000;31;75 Suppl 1:S9-15; discussion S17-9.
3. Cid MC, Hernandez-Rodriguez J, Esteban MJ, Cebrian M, Gho YS, Font C, et al. Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis. Circulation 2002;24:1664-71.
4. Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, Lopez-Soto A, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998;41:26-32.